McKinsey & Company, a consulting firm that covers multiple industries including healthcare and life sciences, is under fire for allegedly allowing its employees to work simultaneously for big pharma companies and serve as consultants for the U.S. Food and Drug Administration.

Moderna Inc. on late March 17 sought emergency use authorization from U.S. health regulators for a second COVID-19 booster shot, as a surge in cases in some parts of the world fuels fears of another wave of the pandemic.

Moderna is facing additional challenges to patent the COVID-19 vaccine Spikevax, as Arbutus Biopharma and Genevant filed a lawsuit against the company challenging patent infringement.

The U.S. Centers for Disease Control and Prevention is under fire for failing to publish large swaths of hospitalization data related to the COVID-19 pandemic that the organization has collected but failed to make public.

New York Governor Kathy Hochul is ending her state’s mask mandate for most indoor public places, The New York Times reported, joining several states due to lift face-covering rules as the latest COVID-19 surge eases.

Johnson & Johnson during late 2021 quietly shut down the only plant making usable batches of the company’s COVID-19 vaccine, the New York Times reported, citing people familiar with the decision.

Surgeons from NYU Langone Health hit a major milestone in transplantation science after successfully attaching a pig’s kidney to a human patient and watching it work for several hours. 

The U.S. Food and Drug Administration is planning to allow Americans to get a different booster shot of a Covid-19 vaccine than the one initially taken, the New York Times reported on Oct. 18.

The mission of new startup Colossal, which has raised $15 million to date, is to genetically reengineer a cold-resistant elephant with all the core biological traits of the extinct woolly mammoth.

A White House plan to offer Covid-19 booster shots will most likely start during September only with the vaccine made by Pfizer and BioNTech, a narrower initiative than anticipated, a source familiar with the matter said on Sept. 3.